Eckol, a potential inhibitor of aryl hydrocarbon receptor, inhibits proliferation and induces apoptosis in breast cancer cells
The present study was designed to explore phlorotannin eckol protein targets and evaluate the anti-cancer effects of eckol against human breast cancer cells. ProTox-II server and protein-ligand docking analysis deter-mined the aryl hydrocarbon receptor (AhR) as a putative target of eckol. The AhR h...
Main Author: | Pelin Balcik-Ercin |
---|---|
Format: | Article |
Language: | English |
Published: |
Bangladesh Pharmacological Society
2022-09-01
|
Series: | Bangladesh Journal of Pharmacology |
Subjects: | |
Online Access: | https://www.banglajol.info/index.php/BJP/article/view/60353 |
Similar Items
-
The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
by: Stephen Safe, et al.
Published: (2022-11-01) -
Role of aryl hydrocarbon receptors in infection and inflammation
by: Linglan Xu, et al.
Published: (2024-04-01) -
Characterizing Eckol as a Therapeutic Aid: A Systematic Review
by: Bandana Manandhar, et al.
Published: (2019-06-01) -
Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
by: Sarah Y. Kado, et al.
Published: (2023-05-01) -
Protective Effect of Eckol against Acute Hepatic Injury Induced by Carbon Tetrachloride in Mice
by: Shulan Li, et al.
Published: (2018-08-01)